Ex) Article Title, Author, Keywords
Ex) Article Title, Author, Keywords
Recently revised on January 31, 2023
Journal of Veterinary Clinics (J Vet Clin, JVC) is a bimonthly, peer-reviewed, international journal which publishes papers on all aspects of the veterinary clinics. Clinical case reports, scientific research papers, short communications, notes, and review articles covering the diagnosis, treatment and control of animal disease will be considered.
Please read the instructions below carefully for details on the submission of manuscripts, the journal’s requirements and standards as well as information concerning the procedure after a manuscript has been accepted for publication in Journal of Veterinary Clinics. Authors are encouraged to visit the Korean Society of Veterinary Clinics Services site (http://www.ksvc.or.kr/) for further general information on the preparation and submission of articles and figures.
Journal of Veterinary Clinics adheres to ethical guidelines given below for publication and research. For other ethical regulations unspecified in the said guideline, authors may refer to the Good Publication Practice Guidelines for Medical Journals 3rd (Korean Association of Medical Journal Editors, KAMJE; https://www.kamje.or.kr/board/view?b_name=bo_publication&bo_id=13&per_page=) and the International Standards for Editors and Authors by the Committee on Publication Ethics (https://publicationethics.org/guidance/Guidelines). All cases of suspected misconduct will be resolved as per the COPE Flowchart (https://publicationethics.org/guidance/Flowcharts).
Authorship: Authors are responsible for the whole content of each article.
Co-authorship should be based on the following 4 criteria: (1) substantial contributions to the conception or designing of the work; or the acquisition, analysis, or interpretation of data for the work; (2) drafting or revising of the work critically for important intellectual content; (3) final approval of the version to be published; and (4) agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Participation solely in the acquisition of funding or the collection of data does not justify authorship and, except in the case of complex large-scale or multi-centre research, the number of authors should usually not exceed six. Any persons who do not meet the 4 criteria above should be placed as contributors in Acknowledgments section.
Acknowledgements: Under Acknowledgements please specify contributors to the article other than the authors accredited.
When experimental animals are used the methods section must clearly indicate that adequate measures were taken to minimize pain or discomfort. Experiments should be carried out in accordance with the Guidelines laid down by the National Institute of Health (NIH) in the USA regarding the care and use of animals for experimental procedures or with the European Communities Council Directive of 24 November 1986 (86/609/EEC) and in accordance with local laws and regulations.
The Journal reserves the right to reject any paper where there is reason to believe that animals have been subjected to unnecessary or avoidable pain or distress. Where animals have been used in a study, the relevant research ethical or animal welfare or institutional review authority, under which the work was conducted, must be stated. Furthermore, manuscripts describing prospective studies involving client-owned animals should also include documentation of informed client consent.
Ethics of investigation: Papers not in agreement with the guidelines of the 1975 Helsinki Declaration as revised in 2013 will not be accepted for publication (https://www.wma.net/).
Research and publication ethics
Duplicate Publication: Redundant publication is defined as “reporting (publishing or attempting to publish) substantially the same work more than once, without attribution of the original source(s).” Characteristics of reports that are substantially similar include the following: (a) “at least one of the authors must be common to all reports (if there are no common authors, it is more likely plagiarism than redundant publication),” (b) “the subjects or study populations are the same or overlapped,” (c) “the methodology is typically identical or nearly so,” and (d) “the results and interpretation have little or no variations.” When submitting a manuscript, authors should include a letter informing the editor of any potential overlap with other already published material or material being evaluated for publication and should also state how the manuscript submitted to Ann Dermatol differs substantially from this other material. If all or part of the patient population was previously reported, this should be mentioned in the Materials and Methods section, with citations of the appropriate reference(s).
Clinical trials: randomized clinical trials (RCTs) and systematic reviews should be reported according to the CONSORT guidelines available at www.consort-statement.org A CONSORT checklist should be used as a guide before submission of material (CONSORT statement).
Registration of Clinical Trial Research: It is recommended that any research dealing with a clinical trial be registered with a primary national clinical trial registration site such as Clinical Research Information Service (https://cris.nih.go.kr/cris/index.jsp), or other sites accredited by the World Health Organization ICTRP (https://www.who.int/ictrp/en/) and ClinicalTrials.gov (https://clinicaltrials.gov/), a service of the United States National Institutes of Health.
This journal follows the data sharing policy described in “Data Sharing Statements for Clinical Trials: A Requirement of the International Committee of Medical Journal Editors”. The ICMJE’s policy regarding trial registration is explained at http://www.icmje.org/recommendations/browse/publishing-and-editorial-issues/clinical-trial-registration.html#two. If the data sharing plan changes after registration this should be reflected in the statement submitted and published with the manuscript, and updated in the registry record.
Papers reporting protein or DNA sequences will not be accepted without a Genbank accession number. Other supporting data sets must be made available on the publication date from the authors directly.
Conflict of Interest: Authors are required to disclose any possible conflict of interest. These include financial (for example patent, ownership, stock ownership, consultancies, speaker’s fee). Author’s conflict of interest (or information specifying the absence of conflicts of interest) will be published under a separate heading entitled Conflict of Interest.
Journal of Veterinary Clinics requires that sources of institutional, private and corporate financial support for the work within the manuscript must be fully acknowledged, and any potential conflicts of interest noted. This information is a requirement for all manuscripts submitted to the Journal and will be published in a highlighted box on the title page of the article. Please include this information under the separate headings of ‘Source of Funding’ and ‘Conflict of Interest’ immediately after the abstract section of your manuscript.
If the author does not include a conflict of interest statement in the manuscript then the following statement will be included by default: ‘No conflicts of interest have been declared’.
If the whole or part(s) of previously published illustrations are used, permission must be obtained from the copyright holder concerned. It is the author’s responsibility to obtain these in writing and provide copies to the Publishers.
Authors submitting a paper do so on the understanding that the work and its essential substance have not been published before and is not being considered for publication elsewhere. Presentation or publication of part or all of the data in, for instance, congress proceedings, should be clearly declared when the paper is submitted.
The submission of the manuscript by the authors means that the authors automatically agree to assign exclusive license/copyright to The Korean Society of Veterinary Clinics if and when the manuscript is accepted for publication. The work shall not be published elsewhere in any language without the written consent of the publisher. The articles published in this journal are protected by copyright, which covers translation rights and the exclusive right to reproduce and distribute all of the articles printed in the journal. No material published in the journal may be stored on microfilm or videocassettes, in electronic databases and the like, or reproduced photographically without the prior written permission of the publisher.
Correspondence to the journal is accepted on the understanding that the contributing author licenses the publisher to publish the letter as part of the journal or separately from it, in the exercise of any subsidiary rights relating to the journal and its contents.
Upon acceptance of a paper, authors are required to assign the exclusive license to publish their paper to The Korean Society of Veterinary Clinics. Assignment of the exclusive license is a condition of publication and papers will not be passed to the publisher for production unless a license has been assigned. (Papers subject to government or Crown copyright are exempt from this requirement; however, the form still has to be signed). A completed Exclusive License Form must be sent to the address specified on the form, before any manuscript can be published. Authors must send the completed original Exclusive License Form by regular mail upon receiving notice of manuscript acceptance, i.e., do not send the form at submission. Faxing or e-mailing the form does not meet the requirements.
This journal is an open access journal distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided that the original work is properly cited. Author(s) do not need to be permitted for use of tables or figures published in Journal of Veterinary Clinics in other journals, books, or media for scholarly and educational purposes. This is in accordance with the Budapest Open Access Initiative definition of open access.
For questions concerning copyright, please visit Copyright FAQs
Animal experiments are to be undertaken only with the purpose of advancing knowledge and in a manner that avoids unnecessary discomfort to the animals by the use of proper management and laboratory techniques. They shall be conducted in compliance with federal, state and local laws and regulations, and in accordance with the internationally accepted principles and guidelines for the care and use of agricultural, laboratory or experimental animals.
In the interests of the reproducibility of results, accurate information about any test animals used in the experiments (origin, inbreeding etc.), as well as information about the housing conditions (diet, environment etc.), should be given.
The editors and the publisher endeavor to publish all articles as rapidly as possible and in the best possible typographical condition. They request that all authors observe carefully the recommendations laid down in these Instructions for Authors.
Manuscripts should be submitted electronically via the online submission site http://e-jvc.org/. The use of an online submission and peer review site expedites the review and decision-making processes and allows authors to track the status of their own manuscripts. If assistance is needed (or if, for some reason, online submission is not possible) the Editorial Office can be contacted at firstname.lastname@example.org and will readily provide any help users need to upload their manuscripts.
To submit a manuscript, please follow the instructions below.
Submitting Authors will be required to complete an Author Statement upon submission. This may be downloaded from here. Submissions will not be accepted without completion of this statement, which covers authorship, conflicts of interest, ethics, copyright assignment etc. If you are unable to submit electronically, please contact the Journal Editorial Office (email@example.com).
Supplementary data associated with this article can be found, in the online version, at http://www.ksvc.or.kr/.
Manuscripts should be uploaded as Word (.doc) or Rich Text Format (.rft) files (not write-protected) plus separate figure files. GIF, JPEG, PICT or Bitmap files are acceptable for submission, but only high-resolution TIF or EPS files are suitable for printing. The files will be automatically converted to HTML and PDF on upload and will be used for the review process. The text file must contain the entire manuscript including title page, abstract, text, references, and figure legends, but no embedded figures. Figure legends should be included in the file. Manuscripts should be formatted as described below.
All manuscripts submitted to Journal of Veterinary Clinics will be reviewed by at least three experts in the field. Journal of Veterinary Clinics uses single-blinded review. The names of the reviewers will thus not be disclosed to the author submitting a paper.
Authors who wish to appeal the reviewers’ decision and/or comments on their submitted paper may do so by e-mailing the editor with a detailed explanation for why they find reasons to appeal the decision.
The editors’ decision on a paper is final and cannot be appealed.
You may suspend a submission at any point before finally submitting it. To return to a manuscript already in process click on ‘Incomplete Submissions’.
You can access Editorial Manager® (http://www.ksvc.or.kr/) at any time to check the status of your manuscript. The Journal will inform you by e-mail once a decision has been made.
Revised manuscripts should be uploaded within 1 month of authors receiving a decision of minor or major revision. Locate your manuscript under ‘Submissions Needing Revision’ and then click on ‘Revise Submission’ under ‘Actions’.
Publication fee: 450,000 KRW (400 US$)
Journal of Veterinary Clinics verifies the similarity of all submitted manuscripts with the existing literature using the iThenticate tool of the Similarity Check program. For more information on Similarity Check, see https://www.crossref.org/services/similarity-check/.
Papers are invited in the following categories: Review Articles, Scientific Research Papers, Short Communications, Clinical Case Reports and Notes.
The manuscript (including references and figure legends) must be A4 or 8.5 × 11 inch format with 2.5 cm margins, single-spaced typed, sans serif, 12 point font, Helvetica (Swiss) style (e.g. Arial or Verdana), left justified. Each line and page of the manuscript text should be numbered consecutively from the title page.
The structure will vary depending on content. Authors should study the format used in previous issues of the journal for further guidance. Authors are encouraged to discuss prospectively the format and content of a review article with one of the editors prior to submission.
Scientific Papers and Brief Communications
Manuscripts should be arranged as follows: title; authors; affiliation; abstract; 5 key words; text with subdivisions as given below; introduction; materials and methods; results; discussion; conclusions; acknowledgements; references; legends for illustrations.
These are usually a chronological description of the case describing the history, physical findings, differential diagnoses, diagnostic tests, specialist diagnostic procedures, diagnoses, treatments, and outcome. When multiple cases are described (case series), these may be described separately or as a group. Manuscripts should be arranged as follows: title; authors; affiliation; abstract; 5 key words; text with subdivisions as given below; introduction; case report; discussion; conclusions; acknowledgements; references; legends for illustrations.
Authors are requested to write with the minimum of formatting and NOT to write over previous versions, which may contain hidden formatting. Do not enhance text and tables with unnecessary formatting (e.g., small capitals, headers). Software programs that automatically create endnotes and footnotes should not be used. To remove the field formats for any reference manager software, save the final draft then click EDIT - SELECT ALL and press CRTL-SHIFT-F9 together.
Title, Author and Affiliations
The title of the article should be concise but informative. If information in the text has been presented at a scientific meeting, this should be indicated. The first name, middle initial(s), and last name of each author must be given. Professional affiliations of the authors at the time of the study should be indicated. If an author’s affiliation has changed since the study was performed, the author’s new affiliation should be identified.
The correspondence details (name and e-mail address), any conflicts of interest and sources of funding (see ‘Conflict of Interest and Source of Funding’ section) should be stated. A short running head of no more than 40 characters (counting letters and spaces) should also be included.
The abstract should be no more than 250 words.
The abstract should state the purposes of the study or investigation, basic procedures, selection of study subjects or experimental animals, observational and analytical methods, main findings (give specific data and their statistical significance, if applicable), and the principal conclusions. Emphasize new and important aspects of the study or observations.
State the purpose of the article. Summaries the rationale for the study or observation. Give only strictly pertinent references and do not review the subject extensively. Do not include data or conclusions from the work being reported.
Materials and Methods
These should be described in sufficient detail to allow other workers to reproduce the results. References for study design and statistical methods should be to standard works (with pages stated) when possible rather than to papers where designs or methods were originally reported. Specify any statistics computer programs used. Report losses to observation (such as dropouts from a clinical trial).
The methods of data collection and use of statistical analysis will be checked by the referees, editors and, if necessary, a statistician. It is highly recommended that authors consult a professional statistician for advice on complex statistical analyses. It is also recommended that authors provide details of which statistical methods and the p-value, if relevant, have been used for each component of the data set (e.g. P = 0.08; ANOVA).
Drugs and therapeutic agents should be given in the format: drug ingredient (trade name; manufacturer name), e.g. fenbendazole (Panacur; Intervet).
Drug names should follow the recommended International Non-Proprietary Names (rINN) - for more information see the Medicines and Healthcare Products Regulatory Agency (MHRA) website.
Products such as equipment or methods should be given as: Product name (Company name; town or city and country). e.g. Datex CD 200-02 (Datex; Hatfield, UK).
The detailed information about drugs, therapeutic agents and products need only be given once.
Ensure correct use of the terms sex (when reporting biological factors) and gender (identity, psychosocial or cultural factors), and, unless inappropriate, report the sex and/or gender of study participants, the sex of animals or cells, and describe the methods used to determine sex and gender. If the study was done involving an exclusive population, for example in only one sex, authors should justify why, except in obvious cases (e.g., prostate cancer). Authors should define how they determined race or ethnicity and justify their relevance.
Present your results in a logical sequence in the text, tables, and illustrations. Do not repeat in the text data in the tables or illustrations. In manuscripts describing more than one animal, all animals should be assigned a case number.
The discussion should emphasize the new and important aspects of the study and the conclusions that follow from them. Include the implications of the findings and their limitations, including implications for future research. Relate the observations to other relevant studies. Link the conclusions with the goals of the study but avoid unqualified statements and conclusions not completely supported by your data. Avoid claiming priority and alluding to work that has not been completed. State new hypotheses when warranted, but clearly indicate them as such. Recommendations, when appropriate, may be included.
These are to indicate support, advice or technical help that does not justify authorship.
Language and style: The language of publication is English. Authors for whom English is a second language must have their manuscript professionally edited by an English speaking person before submission to make sure the English is of high quality. It is preferred that manuscripts are professionally edited prior to submission.
Methods used and results obtained by the authors should be referred to in the past tense:
Interpretation of results should be in the present tense:
All units of measurement must follow the SI system. Concentrations of solutions should be given as molar concentrations (e.g. mmol/L). All other concentrations should be expressed as percentages. Drug dosages should be given as: e.g. mg/kg; μg/kg; also use ‘once daily’, ‘twice daily’ etc..
Spell out numbers one to ten, keep 11 onwards as numerals. However, use Arabic numerals for numbers used with units of measure (e.g. 9 kg, 5 h, 10 mmol/L). Use h, min, s, for hour, minute, second, respectively.
Abbreviations of biological, medical, chemical, and other terms should only be used when such abbreviations are both internationally recognized and unambiguous. The first use of an abbreviation must be explained by also giving the unabbreviated term.
All biological, medical, chemical, and other names should be given in keeping with the latest international nomenclature. If an animal is being mentioned in the text for the first time, the binomial name should be given, e.g. carp (Cyprinus carpio L.). Thereafter, this can be abbreviated to C. carpio.
Figure legends must be given at the end of the manuscript. Sufficient information should be included to allow the figure to be understood without reference to the text. Authors wishing to use any previously published figures must submit written permission from the copyright holder. Figure legends should be written in the following style:
Tables and Figures
These should be limited to those containing data important to understanding and interpreting results and reducing or clarifying the text.
Type each table (single line spacing) into a separate document. Number tables consecutively in the order of the first citation in the text and supply a brief title for each. Give each column a short or abbreviated heading. Place explanatory material in footnotes, not in the heading. Explain in the footnotes all non-standard abbreviations that are used in each table.
Identify statistical measures of variations such as standard deviation and standard error of the mean.
Ensure that each table is cited in the text.
If you use data from another published or unpublished source obtain written permission and acknowledge fully.
Poor quality images may be removed from a manuscript and where critical to the content may lead to rejection of a manuscript.
Figures should be initially saved in a neutral data format such as TIFF or EPS (JPEG format can be accommodated but must fulfil the format criteria given below). PowerPoint and Word graphics are unsuitable for reproduction. Please do not use any pixel-oriented programmes. Scanned figures (only in TIFF format) should have a resolution of 300 dpi (halftone) or 600 to 1200 dpi (line drawings) in relation to the reproduction size. Photographic material should be of such quality that high-contrast reproductions can be made; photostats of photographs are unacceptable.
Graphics created in the CMYK colour palette (print colours) are preferable to those created in RGB (screen colours) to maximise consistency of print reproduction. Images supplied in RGB will be converted to CMYK for printing; this may lead to some variations in colour representation.
To ensure high-quality reproduction, symbols should be clear and even throughout and of sufficient size, that when reduced for publication, each item will still be legible. Graph axes should be labelled in sans serif (Helvetica or Arial) font. Letters, Numbers and Titles belong in the legends for illustrations, not on the illustrations themselves. When symbols, arrows, numbers or letters are used to identify parts of the illustrations, identify and explain each one clearly in a key.
Limit figures to those that reduce or clarify the text. These should be free of extraneous material, and if portions of the handler, for example, fingers or hands are to be included, particularly adjacent to lesions, they must be gloved. Extraneous material should be removed by a program such as Adobe Photoshop®. Backgrounds should be unobtrusive, preferably uncoloured and of a medium tone such as a light grey untextured background. Conventionally, in ventral recumbency, the photograph is vertical, with the head to the top of the frame and in lateral recumbency, the photograph is horizontal and so is the subject. A light source should be from the top of the frame.
For lower power objectives, thicker histological sections are preferable. Thinner sections are advisable for higher power objectives. Optimal Haematoxylin & Eosin staining ensures the differential eosinophilia of tissue components. Harris’s Haematoxylin is preferred as it produces a bluish-black, nuclear stain. The microscope must be set up for Koehler illumination. In general, the 10× or 20× objective provides the best contrast and visibility of the subject in most sections. The 4× objective should be used only when necessary to show the overall pattern.
Photomicrographs and electron micrographs must have an internal scale marker. To express magnification with an internal scale marker, divide the length of the marker by the original magnification. Magnification bars should be approximately 1 cm long and placed in the lower right corner; 5 mm above the lower margin and with the right end 5 mm from the right margin. For figures that consist of multiple parts, individual parts of the figure should be identified by capital letters embedded in the figure, rather than by describing the location of the part in the legend (e.g., top right).
These must be limited to those that are necessary and must be cited in the text by Arabic numerals immediately after the word, period or comma. Arrange the references section in alphabetical order, by the first author’s surname, and number the entries consecutively. Try to avoid using conference proceedings and abstracts not subjected to stringent peer review as references; ‘unpublished observations’ and ‘personal communications’ may not be used as references, although references to written, not oral, communications may be inserted (in parentheses) in the text. The references must be verified by the author(s) against the original documents. Journal name should be abbreviated in accordance with the style of Index Medicus/Medline (www.nlm.nih.gov/tsd/serials/lji.html). Cite each listed reference in the text by number in parentheses. Follow the styles shown in the example below:
Article in Journal
Soomin Kim1 , Yoonji Kim1 , Ji-Hee Kim1 , Hyeon-Jin Kim1 , Ji-Hye Lee1,2 , Migyeong Geum1,2 , Ha-Jung Kim1,2,*
J Vet Clin 2021; 38(3): 143-146
Sora Lee , Taesik Yun , Yoonhoi Koo , Yeon Chae , Dohee Lee , Dongjoon Choi , Yujin Choi , Hakhyun Kim , Mhan-Pyo Yang , Byeong-Teck Kang*
J Vet Clin 2021; 38(3): 127-134
Sol Kim1 , Kyoungwon Seo2 , Kunho Song1,*
J Vet Clin 2021; 38(6): 269-273
Son-Il Pak1, Tae-Ho Oh2,*
J Vet Clin 2016; 33(2): 97-101
Sun Hwa Kim, Kyoung Won Seo, Kun Ho Song
J Vet Clin 2020; 37(1): 9-14
Kyoung-Ha Moon1,3,*, Sang Lee1,3,*, Chang-Yong Choi2,*, So-Yeon Kim1,*, Chang-Wan Kang4,*, Kyoung-Kap Lee1,*, Young-Min Yun1,3,*
J Vet Clin 2014; 31(1): 6-10